Clinical trial · Interventional
Breast and Cervical Cancer Awareness Training in Visually Impaired Women
The Effect of Awareness Education on Breast and Cervical Cancer Screening Among Visually Impaired Women
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This quasi-experimental study aims to determine whether a breast and cervical cancer awareness training program can increase participation in cancer screening among women with visual impairments. The study also aims to identify barriers to screening and improve knowledge about cancer risk factors and screening methods. The main questions this study will address are: * Does the training increase the rate at which women with visual impairments attend cancer screening appointments? * Does the training improve participants' knowledge about breast and cervical cancer? Participants will: * Receive training on breast and cervical cancer risk factors and screening methods. * Learn how to apply to the Cancer Early Diagnosis, Screening, and Training Center. * Be encouraged to attend cancer screening during the study period. * Have knowledge and screening status assessed before the training, immediately after, and three months later.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Awareness | — | UNRESOLVED | — |
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Early Detection of Cancer | — | UNRESOLVED | — |
| Persons With Visual Disabilities | — | UNRESOLVED | — |
| Uterine Cervical Neoplasms | Cervical Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cancer Screening Awareness Education for Visually Impaired Women | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Cancer Screening Awareness Education (Intervention Group)
- description
- Participants in the experimental group will receive an educational intervention on breast and cervical cancer awareness, including information on risk factors, screening methods, and guidance on how to apply to Cancer Early Diagnosis, Screening, and Training Centers. Participants will also be encouraged to accompany a visually impaired peer to a screening appointment. All participants will complete a pre-test, a post-test immediately after the intervention, and a follow-up test at 3 months.
- interventionNames
- Behavioral: Cancer Screening Awareness Education for Visually Impaired Women
- type
- NO_INTERVENTION
- label
- No Education (Control Group)
- description
- Participants in the control group will not receive any educational intervention during the study period. After the completion of the study, they will be offered the same educational content provided to the experimental group. All participants will complete a pre-test, a post-test at the end of the study period, and a follow-up test at 3 months.
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 40 Years
Show eligibility criteria text
Eligibility Criteria Inclusion Criteria: * Women with only a visual impairment (congenital or acquired) * Able to communicate, speak, and understand Turkish * Voluntarily agree to participate in the study * Over the age of 40 * Have had previous sexual intercourse (Pap smear screening requires sexual activity) Exclusion Criteria: * Diagnosed with breast or cervical cancer * Under the age of 40 * Have not had sexual intercourse before * Have undergone screening for at least one of these two cancer types (breast or cervical) within the last year According to the Turkish Ministry of Health, General Directorate of Public Health, in current screenings conducted in our country, within the breast cancer screening program for women, mammography is recommended every two years for women aged 40-69, and within the cervical cancer screening program, Pap smear and HPV-DNA tests are recommended every five years for women aged 30-65. Since women will be referred by the researchers to KETEM centers after training to undergo mammography and Pap smear screening tests, visually impaired women over the age of 40 who have previously had sexual intercourse will be included in the study, as these two screening tests are performed in this common age group and Pap smear screening requires being sexually active.
References
Publications (0)
Data not yet available